Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,489 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (403)

clinicaltrialsPublishedShowing 401–450 of 1,065 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07537946	Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer	not yet recruiting	Phase 3	400	Tongji HospitalOTHER	1	Apr 17, 2026	clinicaltrials
NCT07537959	Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases	not yet recruiting	N/A	280	Tongji HospitalOTHER	1	Apr 17, 2026	clinicaltrials
NCT07537972